IDEAYA Biosciences to Participate in Upcoming August 2024 Investor Relations Event

SOUTH SAN FRANCISCO, Calif., July 29, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in the upcoming investor relations event. Fireside chat with Yujiro S. Hata, Chief Executive Officer, hosted by Justin Zelin, Director, Biotechnology Research Analyst About IDEAYA Biosciences Forward-Looking Statements Investor and Media Contact IDEAYA Biosciences Andres Ruiz ...